Genoway
Research Genoway (ALGEN) on Bullrun: market cap EUR 21.76M, P/E 23.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALGEN
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 21.76M
- P/E23.5
- Financial periodFY2024
- RevenueEUR 22.06M
- Revenue growth10.0%
- Net incomeEUR 1.83M
- Free cash flowEUR 2.99M
- Gross margin48.4%
Valuation Snapshot
latest market cap is EUR 21.76M; P/E is 23.5.
About Genoway
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines.
Frequently asked questions
What is Genoway's market cap?
Genoway's market capitalization is EUR 21.76M.
What is Genoway's P/E ratio?
Genoway's price-to-earnings (P/E) ratio is 23.5.
What does Genoway do?
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models;